Health Sciences Acquisitions Corporation 2
Health Sciences Acquisitions Corporation 2 (HSAQ) Stock Overview
Key statistics and deep links to earnings, valuation, revenue, dividends, and more.
FMP · HSAQ · as of Jun 9, 2026
Key Statistics
Explore Health Sciences Acquisitions Corporation 2 Data
hsaq stock data · financialsFinancial Snapshot
Full FinancialsCompetitors & Peers
hsaq competitorsHSAQ
AURC
BCSA
HPX
LCA
LVACStock Performance
Full HistoryAbout Health Sciences Acquisitions Corporation 2
Health Sciences Acquisitions Corporation 2 currently lacks active business operations. Its primary objective is to complete a strategic business combination, such as a merger or acquisition, with one …
what is health sciences acquisitions corporation 2 · hsaq stock overview · health sciences acquisitions corporation 2 company profile · who is health sciences acquisitions corporation 2 ceo · hsaq NASDAQ · health sciences acquisitions corporation 2 headquarters · health sciences acquisitions corporation 2 business segments
About Stock Overview & Key Data
Health Sciences Acquisitions Corporation 2 (HSAQ) is a Financial Services company in the Shell Companies industry, listed on NASDAQ since Aug 4, 2020. As of the latest trading session, HSAQ stock price is $13.31, with a market capitalization of $149.2M. The stock has returned +34.72% over the past 12 months and +32.57% year-to-date.
In fiscal year 2025, Health Sciences Acquisitions Corporation 2 reported revenue of $33.5M. For detailed financial data including revenue history, earnings, and balance sheet — use the tabs above.
Frequently Asked Questions
As of the latest trading session, Health Sciences Acquisitions Corporation 2 (HSAQ) stock price is $13.31. The stock is traded on NASDAQ under the ticker symbol HSAQ. The 52-week range is $9.41 – $13.80.